{"database": "lobbying", "table": "lobbying_activities", "rows": [[2639655, "171d882f-aebf-4027-a334-b5afdb3d3f46", "Q2", "KOUNTOUPES DENHAM CARR & REID, LLC", 320918, "GLENMARK PHARMACEUTICALS, INC., USA", 2021, "second_quarter", "PHA", "Issues related to the implementation of H.R. 1319, the American Rescue Plan.  Issues related to affordability, essential medicine manufacturing and supply chain, and pricing of pharmaceuticals.  General issues related to the generic drug industry.  Issues related to H.R. 2853, the BLOCKING Act of 2021.", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2021-07-16T11:58:29.223000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2639655"], "units": {}, "query_ms": 62.645142897963524, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}